drugset / Trial / NCT04064619

Compare Sudden Stopping and Weaning of Anticholinergics in Recurrence of OAB Symptoms

NCT04064619

Completed 60 enrolled Beni-Suef University
RandomizedParallel-groupOpen-labelTreatment

Summary

Our study included 60 patients with idiopathic OAB and treated with solifenacin 5mg twice daily for one month. After improvement of their condition, we divided the responders into 2 groups, group I stopped the drug suddenly, while group II underwent gradual weaning of the drug.

Timeline

Start
2018-01-01
Primary completion
2019-08-02
Completion
2019-08-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Solifenacin Small molecule 5 mg

Indications